[go: up one dir, main page]

SI1458861T1 - Ides, an igg-degrading enzyme of streptococcus pyogenes - Google Patents

Ides, an igg-degrading enzyme of streptococcus pyogenes

Info

Publication number
SI1458861T1
SI1458861T1 SI200231066T SI200231066T SI1458861T1 SI 1458861 T1 SI1458861 T1 SI 1458861T1 SI 200231066 T SI200231066 T SI 200231066T SI 200231066 T SI200231066 T SI 200231066T SI 1458861 T1 SI1458861 T1 SI 1458861T1
Authority
SI
Slovenia
Prior art keywords
ides
igg
degrading enzyme
streptococcus pyogenes
pyogenes
Prior art date
Application number
SI200231066T
Other languages
Slovenian (sl)
Inventor
Pawel-Rammingen Ulrich Von
Bjorn Johansson
Lars Bjorck
Original Assignee
Hansa Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1458861(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hansa Medical Ab filed Critical Hansa Medical Ab
Publication of SI1458861T1 publication Critical patent/SI1458861T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI200231066T 2001-12-18 2002-12-17 Ides, an igg-degrading enzyme of streptococcus pyogenes SI1458861T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0130228.0A GB0130228D0 (en) 2001-12-18 2001-12-18 Protein
EP02804912.0A EP1458861B1 (en) 2001-12-18 2002-12-17 Ides, an igg-degrading enzyme of streptococcus pyogenes
PCT/EP2002/014427 WO2003051914A2 (en) 2001-12-18 2002-12-17 Ides, an igg-degrading enzyme of streptococcus pyogenes

Publications (1)

Publication Number Publication Date
SI1458861T1 true SI1458861T1 (en) 2016-02-29

Family

ID=9927839

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200231066T SI1458861T1 (en) 2001-12-18 2002-12-17 Ides, an igg-degrading enzyme of streptococcus pyogenes

Country Status (9)

Country Link
US (2) US7666582B2 (en)
EP (2) EP1458861B1 (en)
AU (1) AU2002366285A1 (en)
DK (1) DK1458861T3 (en)
ES (1) ES2559274T3 (en)
GB (1) GB0130228D0 (en)
HK (1) HK1218308A1 (en)
SI (1) SI1458861T1 (en)
WO (1) WO2003051914A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0511769D0 (en) * 2005-06-09 2005-07-20 Hansa Medical Ab Treatment
PL1901773T3 (en) * 2005-06-09 2012-09-28 Hansa Medical Ab Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
US8691544B2 (en) * 2007-05-04 2014-04-08 Glycorex Transplantation Ab Material for separation of a biomolecule
PL2188306T3 (en) * 2007-08-10 2017-01-31 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
US8501907B2 (en) * 2007-08-10 2013-08-06 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
DK2190984T3 (en) 2007-09-14 2013-12-02 Genovis Ab Methods and kits for purifying and detecting glycosylated IgG
CA2709029A1 (en) 2007-12-21 2009-07-02 Bianca Eser Stability testing of antibodies
EP2304439A4 (en) * 2008-05-29 2012-07-04 Nuclea Biotechnologies Llc Anti-phospho-akt antibodies
JP5461586B2 (en) * 2009-02-09 2014-04-02 ロシュ グリクアート アクチェンゲゼルシャフト Immunoglobulin glycosylation pattern analysis
EP2498812A4 (en) * 2009-11-13 2013-05-22 Bengt Guss Immunizing composition for reducing streptococcal infections
CA2822366A1 (en) 2010-12-23 2012-06-28 Janssen Biotech, Inc. Active protease-resistant antibody fc mutants
GB201103780D0 (en) 2011-03-04 2011-04-20 Hansa Medical Ab Treatment for ige-mediated disease
GB201115841D0 (en) 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201201314D0 (en) 2012-01-26 2012-03-07 Isis Innovation Composition
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
WO2017134274A1 (en) * 2016-02-04 2017-08-10 Ulrich Von Pawel-Rammingen New streptococcal proteases
WO2017205741A1 (en) 2016-05-27 2017-11-30 Genentech, Inc. Bioanalytical method for the characterization of site-specific antibody-drug conjugates
WO2018093868A1 (en) * 2016-11-16 2018-05-24 University Of Florida Research Foundation, Inc. Immunoglobulin proteases, compositions, and uses thereof
CA3133388A1 (en) 2019-03-14 2020-09-17 Janssen Biotech, Inc. Methods for producing anti-tnf antibody compositions
MA55282A (en) 2019-03-14 2022-01-19 Janssen Biotech Inc MANUFACTURING METHODS FOR THE PRODUCTION OF ANTI-TNF ANTIBODY COMPOSITIONS
CN113825765A (en) 2019-03-14 2021-12-21 詹森生物科技公司 Method for producing anti-IL 12/IL23 antibody composition
CA3133383A1 (en) 2019-03-14 2020-09-17 Janssen Biotech, Inc. Methods for producing anti-tnf antibody compositions
JP2022548197A (en) 2019-12-06 2022-11-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ANTI-VEGF PROTEIN COMPOSITION AND METHOD FOR MANUFACTURE THEREOF
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
CN115803009A (en) 2020-05-08 2023-03-14 瑞泽恩制药公司 VEGF traps and microwells and methods for treating ocular diseases and cancer
GB202007431D0 (en) 2020-05-19 2020-07-01 Hansa Biopharma AB Cysteine protease
US20230374542A1 (en) 2020-10-07 2023-11-23 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21)
WO2022221529A1 (en) 2021-04-16 2022-10-20 Asklepios Biopharmaceutical, Inc. Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
WO2022266044A1 (en) * 2021-06-15 2022-12-22 The University Of North Carolina At Chapel Hill Methods and compositions for depleting antibodies
JP2024526736A (en) 2021-07-13 2024-07-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド De novo protein N-terminal sequencing by site-selective dimethylation
WO2024057095A1 (en) 2022-09-14 2024-03-21 Genovis Ab Mutant protease
CN118853710A (en) * 2022-11-08 2024-10-29 上海泰昶生物技术有限公司 Engineering strain and process for producing immunoglobulin G degrading enzyme
CN115998690B (en) * 2022-11-10 2024-07-26 上海泰昶生物技术有限公司 Freeze-dried preparation containing immunoglobulin G degrading enzyme and preparation process thereof
US12091694B2 (en) 2022-11-18 2024-09-17 Seismic Therapeutic, Inc. Fc fusion molecules and uses thereof
EP4646476A1 (en) 2023-01-06 2025-11-12 Seismic Therapeutic, Inc. Protease variants and uses thereof
WO2024206953A2 (en) * 2023-03-29 2024-10-03 Taktos Therapeutics Inc. Ides variant proteins and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2233977B (en) * 1989-01-04 1993-03-31 Michael Kehoe Cytolytic streptolysin o mutants and uses
US5976542A (en) 1996-09-23 1999-11-02 New England Medical Center Compositions and methods for treatment of streptococcus pneumoniae infection
ATE394489T1 (en) * 1998-12-23 2008-05-15 Id Biomedical Corp STREPTOCOCCUS ANTIGENS
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein

Also Published As

Publication number Publication date
AU2002366285A8 (en) 2003-06-30
US7666582B2 (en) 2010-02-23
WO2003051914A2 (en) 2003-06-26
EP1458861B1 (en) 2015-11-04
HK1218308A1 (en) 2017-02-10
WO2003051914A3 (en) 2004-03-04
US20050119464A1 (en) 2005-06-02
EP1458861A2 (en) 2004-09-22
EP2949749A1 (en) 2015-12-02
ES2559274T3 (en) 2016-02-11
AU2002366285A1 (en) 2003-06-30
GB0130228D0 (en) 2002-02-06
US20070237784A1 (en) 2007-10-11
DK1458861T3 (en) 2016-02-01

Similar Documents

Publication Publication Date Title
AU2002366285A8 (en) Ides, an igg-degrading enzyme of streptococcus pyogenes
MXPA03005960A (en) Novel mixtures of microbial enzymes.
AU2002357860A8 (en) Enzymes
AU7961401A (en) Subtilase enzymes
AU2002259196A1 (en) Gene expression profiling
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2002358699A1 (en) New glycosyl hydrolases
WO2003035617A3 (en) Derivatives of uk-2a
GB0017387D0 (en) Novel enzyme
IL158328A0 (en) Surface proteins of streptococcus pyogenes
MXPA03007130A (en) Peg-conjugates of hgt-nk4.
GB0006733D0 (en) Enzyme
AU2002342866A1 (en) Improved washing system
AU2002347778A1 (en) Enzymes
AU2001238407A1 (en) Esterase enzymes having selective activity
EP1424396A4 (en) Sulfated fucogalactan digesting enzyme gene
AU2002257273A1 (en) Enzymes
EP1420813A4 (en) Pregnancy-related enzyme activity
AU2002236595A1 (en) Enzymes
AUPR482001A0 (en) Metal-handling enzymes
GB0017323D0 (en) Enzyme
GB0121840D0 (en) Modified enzyme
GB0102946D0 (en) Enzyme
AU2003246495A1 (en) Polypeptide of streptococcus pyogenes
ZA200304986B (en) Novel mixtures of microbial enzymes.